Back to Search
WILLIAM KINLAW, MD
MD
Neurological Surgery Physician
NPI: 1427331727Individual
Specialties, Licenses & Credentials
Research & Publications (9)
Spot 14: A marker of aggressive breast cancer and a potential therapeutic target.
PMID 16809441·Endocrinology·2006
6-review
Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
PMID 16343103·Clin Endocrinol (Oxf)·2005
8-other
Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.
PMID 19116881·Nutr Cancer·2009
8-other
The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.
PMID 18259941·Cancer Invest·2008
8-other
Long-term response of pituitary carcinoma to temozolomide. Report of two cases.
PMID 17044568·J Neurosurg·2006
5-case
Expression of "Spot 14" (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker.
PMID 16552628·Breast Cancer Res Treat·2006
8-other
S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth.
PMID 16300755·Exp Cell Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 96 JONATHAN LUCAS ST
CHARLESTON, SC 29425 - Phone
- (843) 792-7031
Quick Facts
- NPI
- 1427331727
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile